Reevaluation of glypican-3 as a serological marker for hepatocellular carcinoma.
about
Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinomaCan serum glypican-3 be a biomarker for effective diagnosis of hepatocellular carcinoma? A meta-analysis of the literaturePerioperative plasma glypican-3 level may enable prediction of the risk of recurrence after surgery in patients with stage I hepatocellular carcinoma.Inhibition of circulating dipeptidyl peptidase 4 activity in patients with metastatic prostate cancer.Critical analysis of the potential of targeting GPC3 in hepatocellular carcinoma.Glypican-3 level assessed by the enzyme-linked immunosorbent assay is inferior to alpha-fetoprotein level for hepatocellular carcinoma diagnosis.Glypican-3 antibodies: a new therapeutic target for liver cancer.Characterization of a new monoclonal anti-glypican-3 antibody specific to the hepatocellular carcinoma cell line, HepG2.Update on biomarkers of hepatocellular carcinoma.Engineering α-fetoprotein-based gene vaccines to prevent and treat hepatocellular carcinoma: review and future prospects.Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment.GPC-HCC model: a combination of glybican-3 with other routine parameters improves the diagnostic efficacy in hepatocellular carcinoma.Reevaluation of glypican-3 as a prognostic marker in HCC using X-tile software.Golgi protein 73, not Glypican-3, may be a tumor marker complementary to α-Fetoprotein for hepatocellular carcinoma diagnosis.Overexpression of glypican-3 is a predictor of poor prognosis in hepatocellular carcinoma: An updated meta-analysis.
P2860
Q26772321-EFB80087-747B-4404-A765-7F5240285444Q27023427-90E9E7A0-528D-4171-8C3A-202AFFD40DE0Q33914169-2A2856FC-B551-43EC-B417-1FC8B2E90066Q34468372-6B58EDA1-1894-4F3B-A856-AE46A4F3389FQ37031710-D641E7A2-7AAD-47DC-9823-8500D8C8FDE2Q37343300-A4A8A330-A3BD-4DF6-A8EA-72696022076BQ37625736-6D99552D-67AE-495C-97B1-AC81478EF645Q37685728-C182BB6F-686E-455D-8C91-2F99279B9494Q38166133-00D0D327-92E7-41FC-83EC-FF3E2EB80CCDQ38231581-848BCB4B-AA59-4998-BD79-833CB5FE2DD5Q39378285-CA3BE7C5-A76D-414D-AAE9-741C05A96CE5Q39630392-9327157B-9136-492D-9005-2924418C92C5Q41644454-0631A1B6-38F6-49A0-B82B-8A45051EC8BCQ42255428-ABAA39CD-26BF-4243-BE77-1134F3FB0417Q55478019-EBBF2FD2-F57F-41AD-A682-9978622E6341
P2860
Reevaluation of glypican-3 as a serological marker for hepatocellular carcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Reevaluation of glypican-3 as a serological marker for hepatocellular carcinoma.
@en
Reevaluation of glypican-3 as a serological marker for hepatocellular carcinoma.
@nl
type
label
Reevaluation of glypican-3 as a serological marker for hepatocellular carcinoma.
@en
Reevaluation of glypican-3 as a serological marker for hepatocellular carcinoma.
@nl
prefLabel
Reevaluation of glypican-3 as a serological marker for hepatocellular carcinoma.
@en
Reevaluation of glypican-3 as a serological marker for hepatocellular carcinoma.
@nl
P2093
P1433
P1476
Reevaluation of glypican-3 as a serological marker for hepatocellular carcinoma.
@en
P2093
Gengsun Qian
Jianwei Cui
Jing Zhang
Weizhong Cheng
Zhengxian Ni
P304
P356
10.1016/J.CCA.2013.04.026
P577
2013-05-02T00:00:00Z